INmune Bio, Inc.INMBNASDAQ

|||

Switch Symbol:

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Loading chart...

Alerts

Want to monitor INMB?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor INMB

Key Statistics

About

INmune Bio, Inc. is a publicly traded, clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. INmune Bio has two product platforms.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology

www.inmunebio.com →

News

BREAKING: Ralliant Corporation Investigated for Securities Fraud Following Goodwill Impairment; Investors Should Contact Block & Leviton to Potentially Recover Losses

globenewswire.com

MetLife, Inc. (MET) Q4 2025 Earnings Call Transcript

seekingalpha.com

CellaVision AB (publ) (CLVSF) Q4 2025 Earnings Call Transcript

seekingalpha.com

Konecranes Plc (KNCRY) Q4 2025 Earnings Call Transcript

seekingalpha.com

Elf Beauty shares slip as guidance lift falls short of expectations

proactiveinvestors.com

Palantir: Buy The Recent Drop (Upgrade)

seekingalpha.com

Is Peloton Interactive a Zombie Stock — Dead, but Doesn't Know It Yet?

247wallst.com

Sales are Underway at New Waterfront Townhome Community by Toll Brothers, 400 Lake at Asbury Park, in New Jersey

globenewswire.com

Motorola to Report Q4 Earnings: Can Strong Revenues Drive Growth?

zacks.com

Will SoundHound Stock Gain From AI Recognition and Rankings?

zacks.com

Why Alphabet's stock is falling despite booming cloud growth

marketwatch.com

Disney Stock Crashes 5%. Here's Why Investors Are Getting A White-Knuckle Ride

forbes.com

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Ultragenyx Pharmaceutical Inc. (RARE) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

globenewswire.com

Novo Nordisk CEO: Hims' $49 compounded Wegovy pill a 'waste' of money

reuters.com

Verizon consumer division head departing as company mounts turnaround effort

reuters.com

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

Key Statistics

About

News

UDR Set to Report Q4 Earnings: What's in Store for the Stock?

Can Intuitive Surgical Sustain Robust Top-line Growth in 2026?

Boot Barn Q3 Earnings & Sales Meet Estimates, FY26 Guidance Up

Linde Q4 Earnings Beat on Higher Americas Pricing, Revenues Rise Y/Y

T-Mobile Set to Report Q4 Results: Can Revenue Growth Lift Earnings?

BREAKING: Ralliant Corporation Investigated for Securities Fraud Following Goodwill Impairment; Investors Should Contact Block & Leviton to Potentially Recover Losses

MetLife, Inc. (MET) Q4 2025 Earnings Call Transcript

CellaVision AB (publ) (CLVSF) Q4 2025 Earnings Call Transcript

Konecranes Plc (KNCRY) Q4 2025 Earnings Call Transcript

Elf Beauty shares slip as guidance lift falls short of expectations

Palantir: Buy The Recent Drop (Upgrade)

Is Peloton Interactive a Zombie Stock — Dead, but Doesn't Know It Yet?

Sales are Underway at New Waterfront Townhome Community by Toll Brothers, 400 Lake at Asbury Park, in New Jersey

Motorola to Report Q4 Earnings: Can Strong Revenues Drive Growth?

Will SoundHound Stock Gain From AI Recognition and Rankings?

Why Alphabet's stock is falling despite booming cloud growth

Disney Stock Crashes 5%. Here's Why Investors Are Getting A White-Knuckle Ride

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Ultragenyx Pharmaceutical Inc. (RARE) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

Novo Nordisk CEO: Hims' $49 compounded Wegovy pill a 'waste' of money

Verizon consumer division head departing as company mounts turnaround effort

Explore More

Key Statistics

UDR Set to Report Q4 Earnings: What's in Store for the Stock?

Can Intuitive Surgical Sustain Robust Top-line Growth in 2026?

Boot Barn Q3 Earnings & Sales Meet Estimates, FY26 Guidance Up

Linde Q4 Earnings Beat on Higher Americas Pricing, Revenues Rise Y/Y

T-Mobile Set to Report Q4 Results: Can Revenue Growth Lift Earnings?

BREAKING: Ralliant Corporation Investigated for Securities Fraud Following Goodwill Impairment; Investors Should Contact Block & Leviton to Potentially Recover Losses

MetLife, Inc. (MET) Q4 2025 Earnings Call Transcript

CellaVision AB (publ) (CLVSF) Q4 2025 Earnings Call Transcript

Konecranes Plc (KNCRY) Q4 2025 Earnings Call Transcript

Elf Beauty shares slip as guidance lift falls short of expectations

Palantir: Buy The Recent Drop (Upgrade)

Is Peloton Interactive a Zombie Stock — Dead, but Doesn't Know It Yet?

Sales are Underway at New Waterfront Townhome Community by Toll Brothers, 400 Lake at Asbury Park, in New Jersey

Motorola to Report Q4 Earnings: Can Strong Revenues Drive Growth?

Will SoundHound Stock Gain From AI Recognition and Rankings?

Why Alphabet's stock is falling despite booming cloud growth

Disney Stock Crashes 5%. Here's Why Investors Are Getting A White-Knuckle Ride

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Ultragenyx Pharmaceutical Inc. (RARE) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

Novo Nordisk CEO: Hims' $49 compounded Wegovy pill a 'waste' of money

Verizon consumer division head departing as company mounts turnaround effort